Invivyd to Host Conference Call Discussing Second Quarter 2024 Financial Results and Business Highlights

Core Viewpoint - Invivyd, Inc. will host a conference call on August 14, 2024, to discuss its Q2 financial results and recent business highlights [1]. Company Overview - Invivyd, Inc. is a biopharmaceutical company focused on providing protection against serious viral infectious diseases, starting with SARS-CoV-2 [3]. - The company utilizes its proprietary INVYMAB™ platform, which integrates advanced viral surveillance, predictive modeling, and antibody engineering to rapidly generate new monoclonal antibodies (mAbs) [3]. - In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb, marking the beginning of a series of innovative antibody candidates [3].